Nicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company, announced that resultsfrom the Dolomites Phase 2 clinical trial on NCX 470 in patients with open-angle glaucoma or ocular hypertensionwill be presented by Dr. David Wirta, Medical Director, Eye Research Foundation (Newport Beach, CA, USA), at the World Glaucoma E-Congress 2021 being held from June 30 – July 3, 2021. Dr. Wirta is one of the clinical investigators in the Dolomites trial.
June 23, 2021
· 3 min read